Hyperkalaemia
51 results
1 - 51
Hyperkalaemia - Emergency interventions for hyperkalaemia
- Potassium binders for chronic hyperkalaemia in people with chronic kidney disease
- Trimethoprim or trimethoprim-sulfamethoxazole and risk of hyperkalaemia among patients taking renin-angiotensin system blockers
- Acute kidney injury
- Hypokalaemia
- Drugs for chronic heart failure with preserved ejection fraction
- Drug treatment for hypertension
- Rhabdomyolysis
- Addison's disease and other conditions inducing hypocortisolism
- Drugs commonly causing poisonings
- Aldosterone antagonists for preventing the progression of chronic kidney disease
- Treatment of chronic renal failure
- Diabetic kidney disease (diabetic nephropathy)
- Hypertension in elderly patients
- Chronic heart failure
- Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking renin-angiotensin system blockers
- Antihypertensive agents for preventing diabetic kidney disease
- Increased blood creatinine concentration, eGFR and renal function tests
- Dialysis patient in primary health care
- Secondary hypertension
- Dilated cardiomyopathy
- Early treatment with ACE inhibitors in acute myocardial infarction
- Blood transfusion: indications, administration and adverse reactions
- Low‐sodium salt substitutes and blood pressure
- Interpretation of adult ECG
- Urinary tract infections
- Acne
- Comprehensive treatment and follow-up of type 2 diabetes
- Acute heat illnesses
- Aldosterone receptor antagonists spironolactone and eplerenone for congestive heart failure
- SGLT-2 inhibitors and GLP-1 agonists for diabetes and chronic kidney disease
- SGLT-2 inhibitors in type 2 diabetes
- Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
- Acute coronary syndrome
- Mental disorders due to somatic disease